LogicBio Therapeutics

-$0.11 (-2.42%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell LOGC and other stocks, options, and ETFs commission-free!

About LOGC

LogicBio Therapeutics, Inc. engages in the development of genome editing technology platform. It focuses on the commercialization of GeneRide, which enables the site-specific integration of a therapeutic transgene without nucleases or exogenous promoters by harnessing the native process of homologous recombination.

CEO
Frédéric Chéreau
Employees
39
Headquarters
Lexington, Massachusetts
Founded
2014

LOGC Key Statistics

Market Cap
147.81M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
182.93K
High Today
$4.57
Low Today
$4.34
Open Price
$4.55
Volume
126.53K
52 Week High
$10.00
52 Week Low
$4.34

LOGC Earnings

-$0.51
-$0.34
-$0.17
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
-$0.15 per share
Actual
-$0.32 per share

You May Also Like

UFI
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure